0
Business
Antidepressant Maker Seaport Raises $255 Million in Upsized IPO
May 1, 2026
Scroll
Posted 4 hours ago by
Seaport Therapeutics Inc., a clinical-stage biotechnology company focused on antidepressants and anxiety drugs, raised nearly 255 million in an upsized US initial public offering that priced at the top of its marketed range.
Bloomberg
Coverage and analysis from United States of America. All insights are generated by our AI narrative analysis engine.
United States of America
Bias: lean left
People's Voices (0)
Leave a comment
0/500
Note: Comments are moderated. Please keep it civil. Max 3 comments per day.